Structure-activity relationships for phosphorylation of nucleoside analogs to monophosphates by nucleoside kinases

Acta Biochimica Polonica

Volumn 43, Issue 1, 1996, Pages 143-160

  Johansson, Nils Gunnar ^a   Eriksson, Staffan ^b  

^a MEDIVIR AB   (Sweden)

^b SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

Deoxynucleoside kinase; Nucleoside analog; Nucleotidase; Protein kinase; Salvage kinase enzyme; Structure activity relationships

Indexed keywords

MAMMALIA;

ADENOSINE KINASE; ANTIMETABOLITE; DEOXYCYTIDINE KINASE; DEOXYGUANOSINE KINASE; NUCLEOSIDE; NUCLEOTIDE; PHOSPHOTRANSFERASE; THYMIDINE KINASE;

ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; ENZYME SPECIFICITY; HUMAN; KINETICS; METABOLISM; PHOSPHORYLATION; REVIEW; STRUCTURE ACTIVITY RELATION;

ADENOSINE KINASE; ANIMALS; ANTIMETABOLITES; DEOXYCYTIDINE KINASE; HUMANS; KINETICS; MOLECULAR STRUCTURE; NUCLEOSIDES; NUCLEOTIDES; PHOSPHORYLATION; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); STRUCTURE-ACTIVITY RELATIONSHIP; SUBSTRATE SPECIFICITY; THYMIDINE KINASE;

EID: 0029689120     PISSN: 0001527X     EISSN: None     Source Type: Journal    
DOI: 10.18388/abp.1996_4573     Document Type: Article

References (78)

1. Plagemann, P.G., Wohlhueter, R.M. & Woffendin, C. (1988) Nucleoside and nucleobase transport in animal cells. Biochim. Biophys. Acta 947, 405-443.
2. Plagemann, P.G. & Woffendin, C. (1989) Permeation and salvage of dideoxyadenosine in mammalian cells. Mol. Pharmacol. 36, 185-192.
3. Hurley, M.C., Lin, B.B. & Fox, I.H. (1985) Regulation of deoxyadenosine and nucleoside analog phosphorylation by human placental adenosine kinase. J. Biol. Chem. 260, 15675-15681.
4. Yamada, Y., Goto, H. & Ogasawara, N. (1981) Adenosine kinase from human liver. Biochim. Biophys. Acta 660, 36-43.
5. Arnér, E.S.J. & Eriksson, S. (1995) Mammalian deoxyribonucleoside kinases. Pharmacol. Ther. 67, 155-186.
6. Cohen, A., Barankiewicz, J., Lederman, H.M. & Gelfand, E.W. (1983) Purine and pyrimidine metabolism in human T lymphocytes. Regulation of deoxyribonucleotide metabolism. J. Biol. Chem. 258, 12334-12340.
7. Spyrou, G. & Reichard, R. (1989) Intracellular compartmentation of deoxycytidine nucleotide pools in S phase mouse 3T3 fibroblasts. J. Biol. Chem. 264, 960-964.
8. Spasokoukotskaja, T., Taljanidisz, M., Sasvári-Székely, M. & Staub, M. (1991) Deoxycytidine is salvaged not only into DNA but also into phospholipid precursors. III. dCDP-diacylglycerol formation in tonsillar lymphocytes. Biochem. Biophys. Res. Commun. 174, 680-687.
9. Hrabák, A., Spasokukotskaja, T., Temesi, A. & Staub, M. (1993) The salvage of deoxycytidine into dCDP-diacylglycerol by macrophages and lymphocytes. Biochem. Biophys. Res. Commun. 193, 212-219.
10. Kunz, B.A. (1988) Mutagenesis and deoxyribonucleotide pool imbalance. Mutation Res. 200, 133-147.
11. Meuth, M. (1989) The molecular basis of mutations induced by deoxyribonucleoside triphosphate pool imbalances in mammalian cells. Exp. Cell. Res. 181, 305-316.
12. Shugar, D. (1992) Phosphorylating enzymes involved in activation of chemotherapeutic nucleosides and nucleotides; in Proceedings of the Third International Symposium on Molecular Aspects of Chemotherapy, Gdańsk, Poland, June 19-21, 1991 (Shugar, D., Rode, W. & Borowski, E., eds.) pp. 239-270, Springer Verlag, Berlin, Heidelberg, New York.
13. Plunkett, W. & Saunders, P.P. (1991) Metabolism and action of purine nucleoside analogs. Pharmacol. Ther. 49, 239-268.
14. Ruiz van Haperen, V.W.T. & Peters, G.J. (1994) New targets for pyrimidine antimetabolites for the treatment of solid tumours. 2: Deoxycytidine kinase. Pharm. World Sci. 16, 104-112.
15. Shugar, D. (1974) Progress with antiviral agents. FEBS Lett. 40 (Suppl.), S48-S62.
16. Munch-Petersen, A. (ed.) (1983) Metabolism of Nucleotides, Nucleosides and Nucleobases in Microorganisms. Academic Press, London.
17. Kit, S. (1985) Thymidine kinase. Microbiol. Sci. 2, 369-375.
18. Gentry, G.A. (1992) Viral thymidine kinases and their relatives. Pharmacol. Ther. 54, 319-355.
19. Bohman, C. & Eriksson, S. (1990) Mammalian deoxynucleoside kinases. Biochem (Life Sci. Adv.) 9, 11-35.
20. Weber, G., Singhal, R.L., Abonyi, M., Prajda, N., Hata, Y., Szekeres, T., Yeh, A. & Look, K.Y. (1993) Regulation of deoxycytidine kinase activity and inhibition by DFDC. Adv. Enzyme Regul. 33, 39-59.
21. Ruiz van Haperen, V.W.T., Veerman, G., Braakhuis, B.J.M., Vermoken, J.B., Boven, E., Leyva, A. & Peters, G.J. (1993) Deoxycytidine kinase and deoxycytidine deaminase activities in human tumour xenografts. Eur. J. Cancer 29A, 2132-2137.
22. De Clercq, E. (1992) HIV inhibitors targeted at the reverse transcriptase. AIDS Res. Human Retrovir. 8, 119-134.
23. Schinazi, R.F. (1993) Competitive inhibitors of human immunodeficiency virus reverse transcriptase. Perspect. Drug Discovery & Design 1, 151-180.
24. Johansson, N.G. (1993) Structure, antiviral activity, and chemistry of acyclic nucleoside analogues; in Advances in Antiviral Drug Design (De Clercq, E., ed.) vol. 1, pp. 87-177, JAI Press Inc., London.
25. De Clercq, E. (1984) Pyrimidine nucleoside analogues as antiviral agents; in Targets for the Design of Antiviral Agents. Proc. NATO Advanced Study Institute, Les Arcs, France, June 19-28, 1983 (De Clercq, E. & Walker, R.T., eds.) pp. 203-230, Plenum Press, New York, London.
26. Heinemann, V., Xu, Y.-Z., Chubb, S., Sen, A., Hertel, L.W., Grindey, G.B. et al. (1990) Inhibition of ribonucleotide reduction in CCRF-CEM cells by 2′,2′-difluorodeoxycytidine. Mol. Pharmacol. 38, 567-572.
27. Plunkett, W. (1992) Modulation of deoxycytidylate deaminase in intact human leukaemia cells. Biochem. Pharmacol. 44, 1819-1827.
28. Heinemann, V., Hertel, L.W., Grindey, G.B. & Plunkett, W. (1988) Comparison of the cellular pharmacokinetics and toxicity of 2′,2′-difluorodeoxycytidine and 1-β-D-arabinofuranosyl-cytosine. Cancer Res. 48, 4024-4031.
29. Ruiz van Haperen, V.W.T., Veerman, G., Vermorken, J.B. & Peters, G.J. (1993) 2′,2′-Difluoro-deoxycytidine (gemcitabine) incorporation into DNA and RNA of rumour cell lines. Biochem. Pharmacol. 46, 762-766.
30. Bhalla, K., Holladay, C., Lutzky, J., Ibrado, A.M., Bullock, G., Jasiok, M. et al. (1992) Deoxycytidine protects normal bone marrow progenitors against ara-C and gemcitabine cytotoxicity without compromising their activity against cisplatin-resistant human ovarian cancer cells. Gynaccol. Oncol. 45, 32-39.
31. Tolman, R.L. (1989) Structural requirements for enzymatic activation of acyclonucleotide analogs and the relationship to their mode of antiherpetic action; in Nucleotide Analogues as Antiviral Agents (Martin, J.C., ed.) chapter 3, pp. 35-50, ACS Symposium Series.
32. Eriksson, S., Wang, J., Gronowitz, S. & Johansson, N.G. (1995) Substrate specificities of mitochondrial thymidine kinase and cytosolic deoxycytidine kinase against 5-aryl substituted pyrimidine-2′-deoxyribose analogues. Nucleosides & Nucleotides 14, 507-510.
33. Munch-Petersen, B., Cloos, L., Tyrsted, G. & Eriksson, S. (1991) Diverging substrate specificities of human thymidine kinase 1 and 2 against antiviral dideoxynucleosides. J. Biol. Chem. 266, 9032-9038.
34. Bohman, C. & Eriksson, S. (1988) Deoxycytidine kinase from human leukemic spleen: preparation and characteristics of homogenous enzyme. Biochemistry 27, 4258-4265.
35. Wang, L., Karlsson, A., Arnér, E.S.J. & Eriksson, S. (1993) Substrate specificity of mitochondrial 2′-deoxyguanosine kinase. Efficient phosphorylation of 2-chlorodeoxyadenosine. J. Biol. Chem. 268, 22847-22852.
36. Eriksson, S., Kierdaszuk, B., Munch-Petersen, B., Oberg, B. & Johansson, N.G. (1991) Comparison of the substrate specificities of human thymidine kinase 1 and 2 and deoxycytidine kinase toward antiviral and cytostatic nucleoside analogs. Biochem. Biophys. Res. Commun. 176, 586-592.
37. White, J.C. & Hines, C.H. (1987) Role of uridine triphosphate in the phosphorylation of 1-β-D-arabinofuranosylcytosine by Ehrlich ascites tumour cells. Cancer Res. 47, 1820-1824.
38. White, J.C. & Capizzi, R.L. (1991) A critical role for uridine nucleotides in the regulation of deoxycytidine kinase and the concentration dependence of 1-β-D-arabinofuranosylcytosine phosphorylation in human leukaemia cells. Cancer Res. 51, 2559-2565.
39. Shewach, D.C., Reynolds, K.K. & Hertel, L.W. (1992) Nucleotide specificity of human deoxycytidine kinase. Mol. Pharmacol. 42, 518-524.
40. Coleman, C.N., Stoller, R.G., Drake, J.C. & Chabner, B.A. (1975) Deoxycytidine kinase: properties of the enzyme from human leukemic granulocytes. Blood 46, 791-803.
41. Datta, N.S., Shewach, D.S., Hurley, M.C., Mitchell, B.S. & Fox, I.H. (1989) T-lymphoblast deoxycytidine kinase: purification and properties. Biochemistry 28, 114-123.
42. Datta, N.S., Shewach, D.S., Mitchell, B.S. & Fox, I.H. (1989) Kinetic properties and inhibition of human T-lymphoblast deoxycytidine kinase. J. Biol. Chem. 264, 9359-9364.
43. Ruiz van Haperen, V.W.T., Veerman, G., Vermorken, J.B. & Peters, G.J. (1992) Interaction of metabolism of 2′,2′-difluorodeoxycytidine (gemcitabine, dFdC) with normal pyrimidine metabolism. Proc. Am. Assoc. Cancer Res. 33, Abstr. 182.
44. Johnson, M.A., Johns, D.G. & Fridland, A. (1987) 2′,3′-Dideoxynucleoside phosphorylation by deoxycytidine kinase from normal human thymus extracts: activation of potential drugs for AIDS therapy. Biochem. Biophys. Res. Commun. 148, 1252-1258.
45. Starnes, M.C. & Cheng, Y.-C. (1987) Cellular metabolism of 2′,3′-dideoxycytidine, a compound active against human immunodeficiency virus in vitro. J. Biol. Chem. 262, 988-991.
46. Sarup, J.C., Johnson, M.A., Verhoef, V. & Fridland, A. (1989) Regulation of purine deoxynucleoside phosphorylation by deoxycytidine kinase from human leukemic blast cells. Biochem. Pharmacol. 38, 2601-2607.
47. Kierdaszuk, B., Bohman, C., Ullman, B. & Eriksson, S. (1992) Substrate specificity of human deoxycytidine kinase toward antiviral 2′,3′-dideoxynucleoside analogs. Biochem. Pharmacol. 43, 197-206.
48. Ho, H.-T. & Hitchcock, M.J.M. (1989) Cellular pharmacology of 2′-3′-dideoxy-2′-3′-didehydrothymidine, a nucleoside analog active against human immunodeficiency virus. Antimicrob. Agents Chemother. 33, 844-849.
49. Shewach, D.S., Liotta, D.C. & Schinazi, R.F. (1993) Affinity of the antiviral enantiomers of oxathiolane cytosine nucleosides for human 2′-deoxycytidine kinase. Biochem. Pharmacol. 45, 1540-1543.
50. Van Draanen, N.A., Tisdale, M., Parry, N.G., Jansen, R., Dornisfe, R.E., Tuttle, J.V., Averett, D.R. & Koszalka, G. (1994) Influence of stereochemistry on antiviral activities and resistance profiles of dideoxycytidine nucleotides. Antimicrob. Agents Chemother. 38, 868-871.
51. Bennett, L.L., Jr., Parker, W.B., Allan, P.W., Rose, L.M., Shealy, Y.F., Secrist, J.A., III, Montgomery, J.A., Arnett, G., Kirkman, R.L. & Shannon, W.M. (1993) Phosphorylation of the enantiomers of the carbocyclic analog of 2′-deoxyguanosine in cells infected with herpes simplex virus type 1 and in uninfected cells. Lack of enantiomeric selectivity with the viral thymidine kinase. Mol. Pharmacol. 44, 1258-1266.
52. Bohman, C., Balzarini, J., Wigerinck, P., Van Aerschot, A., Herdewijn, P. & De Clercq, E. (1994) Mechanism of cytostatic action of novel 5-(thien-2-yl)- and 5-(furan-2-yl)-substituted pyrimidine nucleoside analogues against tumor cells transfected by the thymidine kinase gene of herpes simplex virus. J. Biol. Chem. 269, 8036-8043.
53. Persson, T., Hörnfeldt, A.-B., Gronowitz, S. & Johansson, N.G. (1994) Thienyl-substituted nucleosides and their triphosphates. Antiviral Chem. & Chemother. 5, 395-402.
54. Herdewijn, P.A.M.M. (1994) 5-Substituted-2′-deoxyuridines as anti-HSV-1 agents: synthesis and structure activity relationship. Antiviral Chem. & Chemother. 5, 131-146.
55. Wang, J. & Eriksson, S. (1995) Phosphorylation of the antihepatitis B nucleoside analog FIAU (1-[2′-deoxy-2′-fluoro-1-β-D-arabinofuranosyl] -5-iodo-uracil) by human cytosolic and mitochondrial thymidine kinase; implication for cytotoxicity. Submitted to Antimicrob. Agents Chemother.
56. Cheng, Y.-C., Dutchman, G., Fox, J.J., Watanabe, K.A. & Machida, J. (1981) Differential activity of potential antiviral nucleoside analogs on herpes simplex virus-induced and human cellular thymidine kinases. Antimicrob. Agents Chemother. 20, 420-423.
57. Aswell, J.F., Allen, G.P., Jamieson, A.T., Campbell, D.E. & Gentry, G.A. (1977) Antiviral activity of arabinosylthymine in herpesviral replication: mechanism of action in vivo and in vitro. Antimicrob. Agents Chemother. 12, 243-254.
58. Drew, W.L., Miner, R. & King, D. (1991) Antiviral activity of FIAU (1-[2′-deoxy-2′-fluoro-1-β-D-arabinofuranosyl]-5-iodo-uracil) on strains of cytomegalovirus sensitive and resistant to ganciclovir. J. Infect. Dis. 163, 1388-1389.
59. Fourel, I., Li, J., Hantz O., Jacquet, C., Fox, J.J. & Trépo, C. (1992) Effects of 2′-fluorinated arabinosyl-pyrimidine nucleosides on duck hepatitis B virus DNA level in serum and liver of chronically infected ducks. J. Med. Virol. 37, 122-126.
60. Dusheiko, G.M. (1994) Fialuridine toxicity: new hopes and false dawns. Int. Antiviral News 2, 22-23.
61. Colacino, J.M., Malcolm, S.K. & Jaskunas, S.R. (1994) Effect of fialuridine on replication of mitochondrial DNA in CEM cells and in human hepatoblastoma cells in culture. Antimicrob. Agents Chemother. 38, 1997-2002.
62. Höglund, L. (1990) Participation of nucleotidases and substrate cycles in the regulation of pyrimidine deoxynucleotide synthesis. Ph.D. Thesis, Karolinska Institutet.
63. Höglund, L. & Reichard, P. (1990) Cytoplasmic 5′(3′)-nucleotidase from human placenta. J. Biol. Chem. 265, 6589-6595.
64. Höglund, L. & Reichard, P. (1990) Nucleotidase activities in soluble and membrane fractions of three different mammalian cell lines. Exp. Cell Res. 190, 204-208.
65. Spychała, J., Madrid-Marina, V. & Fox, I.H. (1988) High Km soluble 5′-nucleotidase from human placenta. J. Biol. Chem. 263, 18759-18765.
66. Itoh, R. (1993) IMP-GMP 5′-nucleotidase from rat liver. Comp. Biochem. Physiol. 105B, 13-19.
67. Pesi, R., Turriani, M., Allegrini, S., Scolozzi, C., Camici, M., Ipata, P.L. & Tozzi, M.G. (1994) The bifunctional cytosolic 5′-nucleotidase: regulation of the phosphotransferase and nucleotidase activities. Arch. Biochem. Biophys. 312, 75-80.
68. Keller, P.M., McKee, S.A. & Fyfe, J.A. (1985) Cytoplasmic 5′-nucleotidase catalyzes acyclovir phosphorylation. J. Biol. Chem. 260, 8664-8667.
69. Johnson, M.A. & Fridland, A. (1989) Phosphorylation of 2′,3′-dideoxyinosine by cytosolic 5′-nucleotidase of human lymphoid cells. Mol. Pharmacol. 36, 291-295.
70. Miller, W.H., Daluge, S.M., Garvey, E.P., Hopkins, S., Reardon, J.E., Boyd, F.L. & Miller, R.L. (1992) Phosphorylation of carbovir enantiomers by cellular enzymes determines the stereoselectivity of antiviral activity. J. Biol. Chem. 267, 21220-21224.
71. Saunders, P.P., Spindler, C.D., Tan, M.-T., Alvarez, E. & Robins, R.K. (1990) Tiazofurin is phosphorylated by three enzymes from Chinese hamster ovary cells. Cancer Res. 50, 5269-5274.
72. Fridland, A., Connelly, M.C. & Robbins, T.J. (1986) Tiazofurin metabolism in human lymphoblastoid cells: evidence for phosphorylation by adenosine kinase and 5′-nucleotidase. Cancer Res. 46, 532-537.
73. Littler, E., Stuart, A.D. & Chee, M.S. (1992) Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir. Nature (London) 358, 160-162.
74. Sullivan, V., Talarico, C.L., Stanat, S.C., Davis, M., Coen, D.M. & Biron, K.K. (1992) A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells. Nature (London) 358, 162-164.
75. Lurain, N.S., Spafford, L.E. & Thompson, K.D. (1994) Mutation in the UL97 open reading frame of human cytomegalovirus strains resistant to ganciclovir. J. Virol. 68, 4427-4431.
76. Leader, D.P. (1993) Viral protein kinases and protein phosphatases. Pharmacol. Ther. 59, 343-389.
77. Shugar, D. (1995) Protein kinases - enticing targets for antiviral agents. Int. Antiviral News 3, 4-6.
78. Saunders, P.P., Tan, M.-T., Spindler, C.D. & Robins, R.K. (1989) Phosphorylation of 3′-deazaguanosine by nicotinamide riboside kinase in Chinese hamster ovary cells. Cancer Res. 49, 6593-6599.